GTx Announces Webcast for Capesaris®(GTx-758) Analyst Day
GTx Announces Webcast for Capesaris®(GTx-758) Analyst Day
MEMPHIS, Tenn.--(BUSINESS WIRE)-- GTx, Inc. (NAS: GTXI) announced today a webcast discussing Capesaris®(GTx-758) and it's potential role in the treatment of advanced prostate cancer in men is scheduled for Friday, February 15th 2013, from 9:00am - 10:00am Eastern Time. The presentations will be conducted by an expert faculty panel to include: Phillip Kantoff, MD, Dana-Farber Cancer Institute/Brigham and Women's Hospital; Thomas Flaig, MD, University of Colorado School of Medicine; and Evan Yu, MD, Fred Hutchinson Cancer Research Center.
Register for the live webcast at (http://www.media-server.com/m/p/tseh66fk).
GTx, Inc.
Marc Hanover, 901-523-9700
President
KEYWORDS: United States North America Tennessee
INDUSTRY KEYWORDS:
The article GTx Announces Webcast for Capesaris®(GTx-758) Analyst Day originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
